Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial

Araiza-Garaygordobil, D., Gopar-Nieto, R., Sierra-Lara Martínez, D., Belderrain-Morales, N., Sarabia-Chao, V., Alfaro-Ponce, D. L., Ontiveros-Mercado, H., Mendoza-García, S., Altamirano-Castillo, A., Martinez-Amezcua, P., Cabello-López, A., Briseño-De la Cruz, J. L., Ruiz-Beltrán, M., Martínez-Ríos, M. A., Piña-Reyna, Y., Gonzalez-Pacheco, H., & Arias-Mendoza, A. (2022). Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial. High Blood Pressure & Cardiovascular Prevention, 29(5), 463–468. https://doi.org/10.1007/s40292-022-00535-4

Authors:

Diego Araiza-Garaygordobil

Rodrigo Gopar-Nieto

Daniel Sierra-Lara Martínez

Nallely Belderrain-Morales

Vianney Sarabia-Chao

Diana Laura Alfaro-Ponce

Heriberto Ontiveros-Mercado

Salvador Mendoza-García

Alfredo Altamirano-Castillo

Pablo Martinez-Amezcua

Alejandro Cabello-López